KAKyriakos Anastasiadis

Kyriakos Anastasiadis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kyriakos Anastasiadis has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanical circulatory support in cardiogenic shock: a contemporary head-to-head comparison

    by Stavroula A. Siopi, Polychronis Antonitsis, Georgios T. Karapanagiotidis, Georgios Tagarakis, Christos Voucharas, Kyriakos Anastasiadis

    Modern technology has expanded the armamentarium of temporary mechanical circulatory support devices implemented for hemodynamic stabilization of patients in cardiogenic shock. The predominately used ones are intra-aortic balloon pump (IABP), Impella devices, and extracorporeal life support (ECLS) circuits. They are transcutaneous or surgically implanted, utilized for up to 30 days and can either assist or totally replace cardiac function, providing time for myocardial healing (bridge to recovery) or treatment escalation (bridge to destination therapy, bridge to transplantation). In light of the recently published joint consensus of the Perioperative Quality Initiative and Enhanced Recovery After Surgery Cardiac Society on temporary mechanical circulatory support, purpose of the current review is to provide a succinct head-to-head comparison of widely available devices, as well as current escalation, de-escalation and antithrombotic protocols; thus, it proposes immediately translatable device selection and operation algorithms to medical professionals for optimal patient care and effective management of cardiogenic shock.


  • EBCP Expert consensus statement on basic qualifications and competencies for clinical perfusionists in Europe developed in collaboration with EACTS and EACTAIC: Knowledge, skills, and competencies required for contemporary clinical perfusion practice

    by Adrian Bauer, Alexander Wahba, Gudrun Kunst, Kyriakos Anastasiadis, Friedhelm Beyersdorf, Maria A Bruño, Gerdy Debeuckelaere, Deborah Halle, Marloes van Hoeven, Jan Hofland, et al.

    Clinical perfusionists manage and optimize extracorporeal circulation as well as physiological and metabolic stability, to support positive patient outcomes under artificial physiological conditions, such as cardiopulmonary bypass, extracorporeal membrane oxygenation, and other extracorporeal circulation systems. Despite the central role of the profession in patient safety and surgical outcomes, clinical perfusion remains inconsistently defined, regulated, and recognized across Europe. In response to these challenges, the European Board of Cardiovascular Perfusion, together with the European Association for Cardio-Thoracic Surgery and the European Association of Cardiothoracic Anaesthesiology and Intensive Care, convened a multidisciplinary task force to develop a unified expert consensus on the minimum academic education, supervised clinical training, and continuing professional development for safe and independent practice. It defines essential technical competencies, such as the operation of heart-lung machines and mechanical circulatory support devices, alongside critical non-technical skills in decision-making, communication, and interdisciplinary collaboration. The document also introduces a tiered framework to classify perfusionists by experience level and proposes mechanisms for certification and recertification through the European Certificate in Cardiovascular Perfusion. Furthermore, the statement highlights the importance of structured quality assurance programs, simulation-based education, and incident reporting systems in advancing perfusion safety and clinical effectiveness. A harmonized European approach is urgently needed to ensure consistent training standards, enhance workforce mobility, and support formal recognition of clinical perfusion as a regulated healthcare profession. This consensus aims to serve as a benchmark for national regulatory efforts and future professional development across Europe.


  • MiECC should not be restricted to selected patients and experienced teams. A MiECTiS rebuttal to 2024 EACTS/EACTAIC/EBCP guidelines on patient blood management

    by Kyriakos Anastasiadis, Polychronis Antonitsis, Aschraf El-Essawi, Serdar Gunaydin, John Murkin, Mark Bennett, Pascal Starinieri, Ignazio Condello, Cyril Serrick, Thierry Carrel, et al.

  • Open Access

    Minimal invasive extracorporeal circulation versus conventional cardiopulmonary bypass in cardiac surgery: a contemporary systematic review and meta-analysis

    by Kyriakos Anastasiadis, Polychronis Antonitsis, Christos Voucharas, Fani Apostolidou-Kiouti, Apostolos Deliopoulos, Anna-Bettina Haidich, Helena Argiriadou

    OBJECTIVES: The question whether minimally invasive extracorporeal circulation (MiECC) represents the optimal perfusion strategy in cardiac surgery remains unanswered. We sought to systematically review the entire literature and thoroughly address the impact of MiECC versus conventional cardiopulmonary bypass (cCPB) on adverse clinical outcomes after cardiac surgery. METHODS: We searched PubMed, Scopus and Cochrane databases for appropriate articles as well as conference proceedings from major congresses up to 31 August 2024. All randomized controlled trials (RCTs) that fulfilled pre-defined MiECC criteria were included in the analysis. The primary outcome was mortality, while morbidity and transfusion requirements were secondary outcomes. The risk of bias was assessed using the Cochrane Risk of Bias 2 tool. All studies meeting the outcomes of interest of this systematic review were eligible for synthesis. RESULTS: Of the 738 records identified, 36 RCTs were included in the meta-analysis with a total of 4849 patients. MiECC was associated with significantly reduced mortality [odds ratio (OR) 0.66; 95% confidence interval (CI) 0.53–0.81; P = 0.0002; I2 = 0%] as well as risk of postoperative myocardial infarction (OR 0.42; 95% CI 0.26–0.68; P = 0.002; I2 = 0%) and cerebrovascular events (OR 0.55; 95% CI 0.37–0.80; P = 0.007; I2 = 0%). Moreover, MiECC reduced RBC transfusion requirements, blood loss and rate of re-exploration for bleeding together with incidence of atrial fibrillation. This resulted in significantly reduced duration of mechanical ventilation, ICU and hospital stay. CONCLUSIONS: This meta-analysis provides robust evidence for the beneficial effect of MiECC in reducing postoperative morbidity and mortality after cardiac surgery and prompts for a wider adoption of this technology.


  • Open Access

    The fourth report of the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardiothoracic Surgery: focus on standardized outcome ratios

    by Kevin M Veen, Mazen Ahmed, Christoffer Stark, Luca Botta, Kyriakos Anastasiadis, Alexander Bernhardt, Michael Berchtold-Herz, Kadir Caliskan, David Reineke, Kevin Damman, et al.

    OBJECTIVES: This 4th report aimed to provide insights into patient characteristics, outcomes and standardized outcome ratios of patients implanted with durable Mechanical Circulatory Support across participating centres in the European Registry for Patients with Mechanical Circulatory Support (EUROMACS) registry. METHODS: All registered patients receiving durable mechanical circulatory support up to August 2024 were included. The expected number of events was predicted using penalized logistic regression. Standardized outcome ratios (Observed/Expected events) were presented in plots to assess 30-day and 1-year mortality, ischaemic stroke and major bleeding outcomes. Expected events were estimated using penalized logistic regression using demographics and comorbidities as predictors. Centres with <90% follow-up completeness were excluded from standardized outcome ratio assessment. RESULTS: Analysis included 6962 implants in 6408 patients (457 patients underwent repeated implants) registered in EUROMACS from 17 countries (32 centres) (median age: 58 years, 83% males, 17% Interagency Registry for Mechanically Assisted Circulatory Support class 1). Thirty-day mortality, major bleeding and ischaemic stroke probabilities were 9.6, 12.6% and 2.1%, respectively. Standardized mortality ratios showed variability between centres, ranging from 0 (95% CI 0–0) to 1.4 (95% CI 1.2–1.7). Higher standardized bleeding outcome ratios correlated with higher standardized ischaemic stroke ratio’s (Spearman r: 0.56, P = 0.008). CONCLUSIONS: Most included centres perform as expected given the demographics and comorbidities of patients. A positive correlation was found between standardized bleeding and ischaemic stroke ratios, reflecting the need of continuously monitoring of adverse events by quality improvement programs.


  • Miniaturizing cardiopulmonary bypass

    by Kyriakos Anastasiadis, Polychronis Antonitsis, Helena Argiriadou, Apostolos Deliopoulos


  • Open Access

    Respiratory physiotherapy as a key player in the effort to make surgery greener during and beyond the COVID-19 pandemic

    by Georgios Afxonidis, Christos Tsagkaris, Andreas S. Papazoglou, Dimitrios V. Moysidis, Georgios Tagarakis, Christoforos Foroulis, Kyriakos Anastasiadis

  • The European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery: third report

    by Theo M M H de By, Felix Schoenrath, Kevin M Veen, Paul Mohacsi, Julia Stein, Khalid M M Alkhamees, Kyriakos Anastasiadis, Alexander Berhnardt, Friedhelm Beyersdorf, Kadir Caliskan, et al.

    In the third report of the European Registry for Patients with Mechanical Circulatory Support of the European Association for Cardio-Thoracic Surgery, outcomes of patients receiving mechanical circulatory support are reviewed in relation to implant era. Procedures in adult patients (January 2011–June 2020) were included. Patients from centres with P = 0.41). Both Interagency Registry for Mechanically Assisted Circulatory Support class (classes 4–7: 23, 25 and 33%; P < 0.001) and in-hospital deaths (18.5, 17.2 and 11.2; P < 0.001) decreased significantly between eras. Overall, mortality, transplants and the probability of weaning were 55, 25 and 2% at 5 years after the implant, respectively. Major infections were mainly noted early after the implant occurred (AER: 1.44 vs AER>3 months: 0.45). Bilirubin and creatinine levels were significant risk factors in the early phase but not in the late phase after the implant. In its 10 years of existence, EUROMACS has become a point of reference enabling benchmarking and outcome monitoring. Patient characteristics and outcomes changed between implant eras. In addition, both occurrence of outcomes and risk factor weights are time dependent.


  • Use of Minimized Extracorporeal Circulation System in Noncoronary and Valve Cardiac Surgical Procedures—A Case Series

    by Kyriakos Anastasiadis, Omiros Chalvatzoulis, Polychronis Antonitsis, Apostolos Deliopoulos, Helena Argiriadou, Georgios Karapanagiotidis, Dimitrios Kambouroglou, Christos Papakonstantinou

    The aim of this report is to explore application of minimized cardiopulmonary bypass (CPB) circuits in areas of cardiac surgery other than coronary bypass grafting and aortic valve surgery. We report three cases operated under minimal extracorporeal circulation support. Replacement of the descending thoracic aorta was performed in two patients; one with a descending aortic aneurysm and one with pseudoaneurysm formation after previous coarctation repair. We have also implanted a left ventricular assist device for destination therapy. The minimized extracorporeal circulation system provides optimal circulatory support, while it is associated with reduced postoperative morbidity, minimizing the side effects from the use of CPB. Moreover, when off-pump technique is attempted, it can be used as a standby circuit connected to the patient so as to enhance safety of the procedure. Minimized extracorporeal circulation systems can be used with safety and efficacy in a wide range of cardiac surgeries including descending aorta pathology and assist device implantation.